Released last night. TP $3.23 (31% premium to last close)
We are Buy-rated (on CL) on CQE.AX as we believe the current pricing provides an attractive investment opportunity. On GS estimates, the market is pricing in a 14% devaluation of CQE’s portfolio or an implied cap rate of 7.2% (vs. 6.2% book), which we see as overly bearish given continued government funding, exposure to high-quality operators with limited exposure to Victoria, as well as CQE’s solid balance sheet position and improving outlook. Our A$3.23 (was A$3.16), 12-month price target is based on a 42.5%/42.5%/15% blend of our SOTP (A$2.56, was A$2.68), DCF (A$3.80, was A$3.51) and M&A (A$3.50, was A$3.49) valuations, and implies 37% total return vs. our A-REIT coverage average of 17%.
- Forums
- ASX - By Stock
- CQE
- Goldman Sachs report
CQE
charter hall social infrastructure reit
Add to My Watchlist
0.34%
!
$2.98

Goldman Sachs report
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.98 |
Change
0.010(0.34%) |
Mkt cap ! $1.105B |
Open | High | Low | Value | Volume |
$2.97 | $2.98 | $2.94 | $1.191M | 401.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1700 | $2.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.00 | 47434 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1700 | 2.950 |
1 | 1000 | 2.900 |
1 | 190 | 2.890 |
1 | 1068 | 2.880 |
1 | 1045 | 2.870 |
Price($) | Vol. | No. |
---|---|---|
3.000 | 47434 | 8 |
3.020 | 9069 | 2 |
3.040 | 800 | 1 |
3.050 | 6740 | 1 |
3.070 | 3128 | 1 |
Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
Featured News
CQE (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online